Shaun Grady – AstraZeneca
Shaun Grady is Vice-President Business Development Operations, leading AstraZeneca’s transaction execution, due diligence and Alliance and Integration Management function. This includes late-stage as well as on-market licensing and partnering, M & A, and divestments.
His career background includes roles at ICI, Zeneca, and AstraZeneca in Corporate, Pharmaceuticals and US Legal departments, HR and Business Development.
Shaun has worked on major projects including the AstraZeneca merger, creation of Avecia and Syngenta, acquisition of Cambridge Antibody Technology (CAT), MedImmune and Amylin, and the spin out of Albireo. He is also a board member at Healx in Cambridge, which repurposes drugs to treat rare diseases.